Aurora Financial Journal

Medivir Aktiebolag (MVIR.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEKFY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
FY2020
2020-12-31
Income statement
Operating income−SEK 127.3M−SEK 91.4M−SEK 87.4M−SEK 62.1M−SEK 42.9M
Net income−SEK 123.3M−SEK 89.3M−SEK 88.8M−SEK 63.1M−SEK 42.6M
Diluted EPS−SEK 1.08−SEK 1.48−SEK 1.59−SEK 1.20−SEK 1.75
Cash flow
Operating cash flow−SEK 124.2M−SEK 59.7M−SEK 101.8M−SEK 48.7M−SEK 58.1M
Capital expenditureSEK 0SEK 0SEK 382.0KSEK 0SEK 2.7M
Free cash flow−SEK 124.2M−SEK 59.7M−SEK 102.2M−SEK 48.7M−SEK 60.7M
Balance sheet
Cash and equivalentsSEK 62.5MSEK 169.5MSEK 117.4MSEK 221.2MSEK 70.0M
Total assetsSEK 172.6MSEK 287.9MSEK 234.2MSEK 335.8MSEK 191.5M
Total liabilitiesSEK 57.1MSEK 70.0MSEK 41.4MSEK 54.7MSEK 49.6M
Shareholders' equitySEK 115.5MSEK 217.9MSEK 192.8MSEK 281.1MSEK 141.9M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full MVIR.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open MVIR.ST financials →